Summit Therapeutics Files Q1 2025 10-Q
Ticker: SMMT · Form: 10-Q · Filed: May 1, 2025 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
Summit Therapeutics filed its Q1 2025 10-Q, showing financial updates. No major red flags, but keep an eye on cash burn.
AI Summary
Summit Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operations, including changes in common stock and additional paid-in capital during the first quarter of 2025. The company is based in Miami, Florida, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with an update on Summit Therapeutics' financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Summit Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are not fully detailed in this summary but are typical for the industry.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Marks the end of the financial quarter being reported.)
- 2025-05-01 — Filing Date (Indicates when the report was officially submitted to the SEC.)
Key Players & Entities
- Summit Therapeutics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250501 (date) — Filing date
- Miami, FL (location) — Company headquarters
- 305-203-2034 (phone_number) — Company business phone
FAQ
What is the primary business of Summit Therapeutics Inc.?
Summit Therapeutics Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
What is the fiscal year end for Summit Therapeutics Inc.?
The fiscal year end for Summit Therapeutics Inc. is December 31 (1231).
When was the company formerly known as Summit Corp plc?
Summit Therapeutics Inc. was formerly known as Summit Corp plc, with a date of name change on 20140205.
What is the SEC file number for Summit Therapeutics Inc.?
The SEC file number for Summit Therapeutics Inc. is 001-36866.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025 (20250331).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding Summit Therapeutics Inc. (SMMT).